New 'Living Drug' trial offers hope for kids with untreatable autoimmune conditions
NCT ID NCT07283315
Summary
This is a very early study testing a new type of cell therapy for children with severe autoimmune diseases like lupus and scleroderma that haven't improved with standard treatments. Doctors will collect a patient's own immune cells, modify them in a lab to better target the disease, and then infuse them back. The main goals are to see if this approach is safe and if it can help control these difficult diseases.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Children's Hospital of Zhejiang University School of Medicine
RECRUITINGHangzhou, Zhejiang, 310052, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.